Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States.

Tabak YP, Merchant S, Ye G, Vankeepuram L, Gupta V, Kurtz SG, Puzniak LA.

J Hosp Infect. 2019 Jun 19. pii: S0195-6701(19)30259-2. doi: 10.1016/j.jhin.2019.06.005. [Epub ahead of print]

PMID:
31228511
2.

A Combination Antibiogram Evaluation for Pseudomonas aeruginosa in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in U.S. Hospitals.

Puzniak L, DePestel DD, Srinivasan A, Ye G, Murray J, Merchant S, DeRyke CA, Gupta V.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02564-18. doi: 10.1128/AAC.02564-18. Print 2019 Apr.

3.

Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients With Pseudomonas aeruginosa Infection.

Tartof SY, Kuntz JL, Chen LH, Wei R, Puzniak L, Tian Y, Im TM, Takhar HS, Merchant S, Lodise T.

JAMA Netw Open. 2018 Oct 5;1(6):e183927. doi: 10.1001/jamanetworkopen.2018.3927.

4.

Impact of the use of local fidaxomicin treatment algorithms for managing Clostridium difficile infection in hospitalized patients in southeastern United States.

Cho JC, Estrada SJ, Kisgen JJ, Davis A, Puzniak L.

Ann Clin Microbiol Antimicrob. 2018 Oct 11;17(1):37. doi: 10.1186/s12941-018-0288-3.

5.

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.

Raman G, Avendano EE, Chan J, Merchant S, Puzniak L.

Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9. eCollection 2018.

6.

Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).

Shorr AF, Puzniak LA, Biswas P, Niederman MS.

PLoS One. 2015 Jul 21;10(7):e0131932. doi: 10.1371/journal.pone.0131932. eCollection 2015.

7.

Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trials.

Puzniak LA, Quintana A, Wible M, Babinchak T, McGovern PC.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):261-5. doi: 10.1016/j.diagmicrobio.2014.03.001. Epub 2014 Mar 12.

PMID:
24725736
8.

Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.

Caffrey AR, Morrill HJ, Puzniak LA, LaPlante KL.

Clin Ther. 2014 Apr 1;36(4):552-9. doi: 10.1016/j.clinthera.2014.02.013. Epub 2014 Mar 14.

PMID:
24631473
9.

Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.

Caffrey AR, Morrill HJ, Puzniak LA, Laplante KL.

Pharmacotherapy. 2014 May;34(5):473-80. doi: 10.1002/phar.1390. Epub 2014 Jan 13.

PMID:
24420846
10.
11.

Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Puzniak LA, Morrow LE, Huang DB, Barreto JN.

Clin Ther. 2013 Oct;35(10):1557-70. doi: 10.1016/j.clinthera.2013.08.001. Epub 2013 Sep 3.

PMID:
24011955
12.

The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.

Duane TM, Capitano B, Puzniak LA, Biswas P, Joshi M.

Surg Infect (Larchmt). 2013 Aug;14(4):401-7. doi: 10.1089/sur.2012.033. Epub 2013 Jul 16.

PMID:
23859675
13.

Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease.

Duane TM, Weigelt JA, Puzniak LA, Huang DB.

Surg Infect (Larchmt). 2012 Jun;13(3):147-53. doi: 10.1089/sur.2011.062. Epub 2012 May 8.

PMID:
22568921
14.

Echinocandins: are they all the same?

Mukherjee PK, Sheehan D, Puzniak L, Schlamm H, Ghannoum MA.

J Chemother. 2011 Dec;23(6):319-25. Review.

PMID:
22233814
15.

Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain.

Bonilla H, Huband MD, Seidel J, Schmidt H, Lescoe M, McCurdy SP, Lemmon MM, Brennan LA, Tait-Kamradt A, Puzniak L, Quinn JP.

Clin Infect Dis. 2010 Oct 1;51(7):796-800. doi: 10.1086/656281.

PMID:
20726771
16.

Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure.

Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM.

Infect Control Hosp Epidemiol. 2007 Feb;28(2):123-30. Epub 2007 Jan 26.

PMID:
17265392
17.

Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications.

Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, Mundy LM.

Infect Control Hosp Epidemiol. 2006 Oct;27(10):1068-75. Epub 2006 Sep 21.

PMID:
17006814
18.

Bioterrorism knowledge and emergency preparedness among school nurses.

Evers S, Puzniak L.

J Sch Health. 2005 Aug;75(6):232-7. No abstract available.

PMID:
16014131
19.

Has the epidemiology of nosocomial candidemia changed?

Puzniak L, Teutsch S, Powderly W, Polish L.

Infect Control Hosp Epidemiol. 2004 Aug;25(8):628-33.

PMID:
15357152
20.

A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?

Puzniak LA, Gillespie KN, Leet T, Kollef M, Mundy LM.

Infect Control Hosp Epidemiol. 2004 May;25(5):418-24.

PMID:
15188849
21.

To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci.

Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM.

Clin Infect Dis. 2002 Jul 1;35(1):18-25. Epub 2002 Jun 7.

PMID:
12060870
22.

Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit.

Puzniak LA, Mayfield J, Leet T, Kollef M, Mundy LM.

Clin Infect Dis. 2001 Jul 15;33(2):151-7. Epub 2001 Jun 15.

PMID:
11418873

Supplemental Content

Loading ...
Support Center